Patents by Inventor MAX TI-KUANG HOU

MAX TI-KUANG HOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optical method for predicting treatment response, survival and recurrence of esophageal cancer patients
    Patent number: 10746651
    Abstract: The present invention provides an optical method for predicting treatment response, survival and recurrence of esophageal cancer patients, comprising analyzing the spectral signatures of patient's tumor tissue spectra. By the features of the present invention, the prediction result achieves the sensitivity of 75% and specificity of 73.3% in concurrent chemoradiotherapy (CCRT) response; the survival prediction rate achieves the sensitivity of 100%; the recurrence prediction rate achieves the sensitivity of 85.7%.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: August 18, 2020
    Assignee: NATIONAL TAIWAN UNIVERSITY
    Inventors: Jang-Ming Lee, I-Jen Hsu, Max Ti-Kuang Hou, Pei-Wen Yang
  • OPTICAL METHOD FOR PREDICTING TREATMENT RESPONSE, SURVIVAL AND RECURRENCE OF ESOPHAGEAL CANCER PATIENTS
    Publication number: 20190017925
    Abstract: The present invention provides an optical method for predicting treatment response, survival and recurrence of esophageal cancer patients, comprising analyzing the spectral signatures of patient's tumor tissue spectra. By the features of the present invention, the prediction result achieves the sensitivity of 75% and specificity of 73.3% in concurrent chemoradiotherapy (CCRT) response; the survival prediction rate achieves the sensitivity of 100%; the recurrence prediction rate achieves the sensitivity of 85.7%.
    Type: Application
    Filed: September 13, 2017
    Publication date: January 17, 2019
    Inventors: JANG-MING LEE, I-JEN HSU, MAX TI-KUANG HOU, PEI-WEN YANG